Azithromycin: Pfizer – A large-scale, CFFT-conceived and supported, TDN-coordinated trial completed in 2002. In patients with chronic PA, this oral antibiotic improved lung function and weight gain, and decreased hospitalization rate. Two follow up studies are in progress.